fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 1 Sep 2026

INDIGO, full dossier

IndiGo stated that aircraft constraints have not resulted in deferral of any routes or frequencies, and network plans have been adjusted to match aircraft availability.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

IndiGo stated that aircraft constraints have not resulted in deferral of any routes or frequencies, and network plans have been adjusted to match aircraft availability.

thehindubusinessline.com31 Aug 2026

A single act of reporting so far, corroborating sources join this record as they publish.

InterGlobe Aviation

₹4,929.90

▼ -1.09%

Close (EOD), as of 1 Oct 2026 · source

InterGlobe Aviation: results, dividends, orders, the full cited record →

More on InterGlobe Aviation

Goldman Sachs said it remains positive on IndiGo’s growth outlook, citing the airline’s consistent market share gains, favourable industry capacity dynamics, cost leadership and the long-term growth potential of its international business.

29 Sep 2026 · 1 publisher

IndiGo is using a network of 28 bonded stations and major gateways like Delhi, Mumbai, and Bengaluru to connect domestic cargo with international markets.

26 Sep 2026 · 1 publisher

IndiGo's share of India's domestic air passenger market slipped in August 2026, while the Air India Group gained ground.

24 Sep 2026 · 1 publisher

India's domestic air passenger traffic declined 6.34 per cent year-on-year to 121.26 lakh in August.

23 Sep 2026 · 1 publisher

According to Jefferies, the airline industry is entering a phase of near-term rationalisation, with carriers placing greater emphasis on profitability rather than pursuing aggressive capacity expansion.

21 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.